MUC1 and breast carcinoma: Her-2/neu, a cell membrane surface-bound tyrosine kinase, which is involved in the signal transduction pathways leading to cell growth and differentiation, and a glycoprotein MUC1 that can be recognized by CA27–29, a monoclonal antibody, are Food and Drug Administration (FDA) approved cancer biomarkers for monitoring breast cancer (Ludwig and Weinstein, 2005).